Loading data
CGEMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | 0 USD | 18.94 m USD |
| Research and development expense | 187.4 m USD | 142.9 m USD | 148.16 m USD | 91.95 m USD | 57.75 m USD |
| Operating profit | -241.65 m USD | -196.92 m USD | -191.09 m USD | 144.65 m USD | -67.95 m USD |
| Profit before tax | -219.88 m USD | -167.46 m USD | -169.22 m USD | 151.32 m USD | -67.49 m USD |
| Income tax expense | 0 USD | 117 k USD | -14.12 m USD | 42.12 m USD | 0 USD |
| Net income (reported basis) | -219.88 m USD | -167.58 m USD | -155.1 m USD | 111.21 m USD | -65.57 m USD |
| Basic earnings per share | — | — | -3.69 USD/share | 2.46 USD/share | -1.52 USD/share |
| Diluted earnings per share | — | — | -3.69 USD/share | 2.38 USD/share | -1.52 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.